Catalytic activity of matrix metalloproteinase-19 is essential for tumor suppressor and anti-angiogenic activities in nasopharyngeal carcinoma

International Journal of Cancer

Volumn 129, Issue 8, 2011, Pages 1826-1837

  Chan, King Chi ^a   Ko, Josephine Mun Yee ^a   Lung, Hong Lok ^a   Sedlacek, Radislav ^b   Zhang, Zeng Feng ^c   Luo, Dian Zhong ^c   Feng, Zhen Bo ^c   Chen, Shuang ^c   Chen, Honglin ^a   Chan, Kwok Wah ^a   Tsao, Sai Wah ^a   Chua, Daniel Tsin Tien ^a   Zabarovsky, Eugene R ^d   Stanbridge, Eric J ^e   Lung, Maria Li ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b INSTITUTE OF MOLECULAR GENETICS   (Czech Republic)

^c GUANGXI MEDICAL UNIVERSITY   (China)

^d KAROLINSKA INSTITUTE   (Sweden)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

angiogenesis; MMP19; nasopharyngeal carcinoma; tumor suppressor gene

Indexed keywords

MATRIX METALLOPROTEINASE 19; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CARCINOGENICITY; CATALYSIS; COLONY FORMATION; CONTROLLED STUDY; DNA METHYLATION; DOWN REGULATION; ENDOTHELIUM CELL; ENZYME ACTIVITY; GENE DELETION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MICROVASCULAR ENDOTHELIAL CELL; MOUSE; MUTANT; NASOPHARYNX CARCINOMA; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; UMBILICAL VEIN; WILD TYPE;

ANGIOGENESIS INHIBITORS; ANIMALS; CATALYSIS; CELL LINE, TUMOR; DNA METHYLATION; DOWN-REGULATION; HUMANS; LOSS OF HETEROZYGOSITY; MATRIX METALLOPROTEINASES, SECRETED; MICE; MICE, NUDE; NASOPHARYNGEAL NEOPLASMS; TRANSFECTION;

EID: 80051977695     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25855     Document Type: Article

References (45)

1. Chang ET, Adami HO,. The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev 2006; 15: 1765-77. (Pubitemid 44664247)
2. Lo KW, Huang DP,. Genetic and epigenetic changes in nasopharyngeal carcinoma. Semin Cancer Biol 2002; 12: 451-62. (Pubitemid 35370758)
3. Shah KM, Young LS,. Epstein-Barr virus and carcinogenesis: beyond Burkitt's lymphoma. Clin Microbiol Infect 2009; 15: 982-8.
4. Lo KW, Teo PM, Hui AB, To KF, Tsang YS, Chan SY, Mak KF, Lee JC, Huang DP,. High resolution allelotype of microdissected primary nasopharyngeal carcinoma. Cancer Res 2000; 60: 3348-53. (Pubitemid 30482144)
5. Clark IM, Swingler TE, Sampieri CL, Edwards DR,. The regulation of matrix metalloproteinases and their inhibitors. Int J Biochem Cell Biol 2008; 40: 1362-78.
6. Pendas AM, Knauper V, Puente XS, Llano E, Mattei MG, Apte S, Murphy G, Lopez-Otin C,. Identification and characterization of a novel human matrix metalloproteinase with unique structural characteristics, chromosomal location, and tissue distribution. J Biol Chem 1997; 272: 4281-6. (Pubitemid 27078499)
7. Stracke JO, Fosang AJ, Last K, Mercuri FA, Pendas AM, Llano E, Perris R, Di Cesare PE, Murphy G, Knauper V,. Matrix metalloproteinases 19 and 20 cleave aggrecan and cartilage oligomeric matrix protein (COMP). FEBS Lett 2000; 478: 52-6. (Pubitemid 30462257)
8. Titz B, Dietrich S, Sadowski T, Beck C, Petersen A, Sedlacek R,. Activity of MMP-19 inhibits capillary-like formation due to processing of nidogen-1. Cell Mol Life Sci 2004; 61: 1826-33. (Pubitemid 39044260)
9. Sadowski T, Dietrich S, Koschinsky F, Ludwig A, Proksch E, Titz B, Sedlacek R,. Matrix metalloproteinase 19 processes the laminin 5 gamma 2 chain and induces epithelial cell migration. Cell Mol Life Sci 2005; 62: 870-80. (Pubitemid 40655634)
10. Chakraborti S, Mandal M, Das S, Mandal A, Chakraborti T,. Regulation of matrix metalloproteinases: an overview. Mol Cell Biochem 2003; 253: 269-85.
11. Ra HJ, Parks WC,. Control of matrix metalloproteinase catalytic activity. Matrix Biol 2007; 26: 587-96. (Pubitemid 350180394)
12. Sadowski T, Dietrich S, Koschinsky F, Sedlacek R,. Matrix metalloproteinase 19 regulates insulin-like growth factor-mediated proliferation, migration, and adhesion in human keratinocytes through proteolysis of insulin-like growth factor binding protein-3. Mol Biol Cell 2003; 14: 4569-80. (Pubitemid 37444656)
13. Sedlacek R, Mauch S, Kolb B, Schatzlein C, Eibel H, Peter HH, Schmitt J, Krawinkel U,. Matrix metalloproteinase MMP-19 (RASI-1) is expressed on the surface of activated peripheral blood mononuclear cells and is detected as an autoantigen in rheumatoid arthritis. Immunobiology 1998; 198: 408-23. (Pubitemid 28098486)
14. Djonov V, Hogger K, Sedlacek R, Laissue J, Draeger A,. MMP-19: cellular localization of a novel metalloproteinase within normal breast tissue and mammary gland tumours. J Pathol 2001; 195: 147-55. (Pubitemid 32899022)
15. Impola U, Toriseva M, Suomela S, Jeskanen L, Hieta N, Jahkola T, Grenman R, Kahari VM, Saarialho-Kere U,. Matrix metalloproteinase-19 is expressed by proliferating epithelium but disappears with neoplastic dedifferentiation. Int J Cancer 2003; 103: 709-16. (Pubitemid 36110225)
16. Bister VO, Salmela MT, Karjalainen-Lindsberg ML, Uria J, Lohi J, Puolakkainen P, Lopez-Otin C, Saarialho-Kere U,. Differential expression of three matrix metalloproteinases, MMP-19, MMP-26, and MMP-28, in normal and inflamed intestine and colon cancer. Dig Dis Sci 2004; 49: 653-61. (Pubitemid 38992558)
17. Jost M, Folgueras AR, Frerart F, Pendas AM, Blacher S, Houard X, Berndt S, Munaut C, Cataldo D, Alvarez J, Melen-Lamalle L, Foidart JM, et al. Earlier onset of tumoral angiogenesis in matrix metalloproteinase-19-deficient mice. Cancer Res 2006; 66: 5234-41. (Pubitemid 43844947)
18. Lung HL, Bangarusamy DK, Xie D, Cheung AK, Cheng Y, Kumaran MK, Miller L, Liu ET, Guan XY, Sham JS, Fang Y, Li L, et al. THY1 is a candidate tumour suppressor gene with decreased expression in metastatic nasopharyngeal carcinoma. Oncogene 2005; 24: 6525-32. (Pubitemid 41486635)
19. Lung HL, Lo PH, Xie D, Apte SS, Cheung AK, Cheng Y, Law EW, Chua D, Zeng YX, Tsao SW, Stanbridge EJ, Lung ML,. Characterization of a novel epigenetically-silenced, growth-suppressive gene, ADAMTS9, and its association with lymph node metastases in nasopharyngeal carcinoma. Int J Cancer 2008; 123: 401-8. (Pubitemid 351842026)
20. Xie D, Sham JS, Zeng WF, Lin HL, Che LH, Wu HX, Wen JM, Fang Y, Hu L, Guan XY,. Heterogeneous expression and association of beta-catenin, p16 and c-myc in multistage colorectal tumorigenesis and progression detected by tissue microarray. Int J Cancer 2003; 107: 896-902. (Pubitemid 37429830)
21. Lo PH, Lung HL, Cheung AK, Apte SS, Chan KW, Kwong FM, Ko JM, Cheng Y, Law S, Srivastava G, Zabarovsky ER, Tsao SW, et al. Extracellular protease ADAMTS9 suppresses esophageal and nasopharyngeal carcinoma tumor formation by inhibiting angiogenesis. Cancer; 70: 5567-76.
22. Lung HL, Lo CC, Wong CC, Cheung AK, Cheong KF, Wong N, Kwong FM, Chan KC, Law EW, Tsao SW, Chua D, Sham JS, et al. Identification of tumor suppressive activity by irradiation microcell-mediated chromosome transfer and involvement of alpha B-crystallin in nasopharyngeal carcinoma. Int J Cancer 2008; 122: 1288-96. (Pubitemid 351287228)
23. Ko JM, Wong CP, Tang CM, Lau KW, Lung ML,. Frequent loss of heterozygosity on multiple chromosomes in Chinese esophageal squamous cell carcinomas. Cancer Lett 2001; 170: 131-8. (Pubitemid 32709912)
24. Mueller MS, Mauch S, Sedlacek R,. Structure of the human MMP-19 gene. Gene 2000; 252: 27-37. (Pubitemid 30618810)
25. Ko JM, Chan PL, Yau WL, Chan HK, Chan KC, Yu ZY, Kwong FM, Miller LD, Liu ET, Yang LC, Lo PH, Stanbridge EJ, et al. Monochromosome transfer and microarray analysis identify a critical tumor-suppressive region mapping to chromosome 13q14 and THSD1 in esophageal carcinoma. Mol Cancer Res 2008; 6: 592-603. (Pubitemid 351521841)
26. Lung HL, Cheng Y, Kumaran MK, Liu ET, Murakami Y, Chan CY, Yau WL, Ko JM, Stanbridge EJ, Lung ML,. Fine mapping of the 11q22-23 tumor suppressive region and involvement of TSLC1 in nasopharyngeal carcinoma. Int J Cancer 2004; 112: 628-35. (Pubitemid 39425942)
27. Protopopov AI, Li J, Winberg G, Gizatullin RZ, Kashuba VI, Klein G, Zabarovsky ER,. Human cell lines engineered for tetracycline-regulated expression of tumor suppressor candidate genes from a frequently affected chromosomal region, 3p21. J Gene Med 2002; 4: 397-406. (Pubitemid 40277177)
28. Yau WL, Lung HL, Zabarovsky ER, Lerman MI, Sham JS, Chua DT, Tsao SW, Stanbridge EJ, Lung ML,. Functional studies of the chromosome 3p21.3 candidate tumor suppressor gene BLU/ZMYND10 in nasopharyngeal carcinoma. Int J Cancer 2006; 119: 2821-6. (Pubitemid 44846233)
29. Kong D, Li Y, Wang Z, Banerjee S, Sarkar FH,. Inhibition of angiogenesis and invasion by 3,3′-diindolylmethane is mediated by the nuclear factor-kappaB downstream target genes MMP-9 and uPA that regulated bioavailability of vascular endothelial growth factor in prostate cancer. Cancer Res 2007; 67: 3310-9. (Pubitemid 46724870)
30. Garcia-Maceira P, Mateo J,. Silibinin inhibits hypoxia-inducible factor-1alpha and mTOR/p70S6K/4E-BP1 signalling pathway in human cervical and hepatoma cancer cells: implications for anticancer therapy. Oncogene 2009; 28: 313-24.
31. Lung HL, Cheung AK, Xie D, Cheng Y, Kwong FM, Murakami Y, Guan XY, Sham JS, Chua D, Protopopov AI, Zabarovsky ER, Tsao SW, et al. TSLC1 is a tumor suppressor gene associated with metastasis in nasopharyngeal carcinoma. Cancer Res 2006; 66: 9385-92. (Pubitemid 44623634)
32. Hangauer DG, Monzingo AF, Matthews BW,. An interactive computer graphics study of thermolysin-catalyzed peptide cleavage and inhibition by N-carboxymethyl dipeptides. Biochemistry 1984; 23: 5730-41. (Pubitemid 15189726)
33. Lee S, Jilani SM, Nikolova GV, Carpizo D, Iruela-Arispe ML,. Processing of VEGF-A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumors. J Cell Biol 2005; 169: 681-91. (Pubitemid 41002860)
34. Folkman J,. Tumor angiogenesis: therapeutic implications. N Engl J Med 1971; 285: 1182-6.
35. Li J, Wang F, Protopopov A, Malyukova A, Kashuba V, Minna JD, Lerman MI, Klein G, Zabarovsky E,. Inactivation of RASSF1C during in vivo tumor growth identifies it as a tumor suppressor gene. Oncogene 2004; 23: 5941-9. (Pubitemid 39093538)
36. Li J, Wang F, Haraldson K, Protopopov A, Duh FM, Geil L, Kuzmin I, Minna JD, Stanbridge E, Braga E, Kashuba VI, Klein G, et al. Functional characterization of the candidate tumor suppressor gene NPRL2/G21 located in 3p21.3C. Cancer Res 2004; 64: 6438-43. (Pubitemid 39297898)
37. Lung HL, Cheung AK, Cheng Y, Kwong FM, Lo PH, Law EW, Chua D, Zabarovsky ER, Wang N, Tsao SW, Stanbridge EJ, Lung ML,. Functional characterization of THY1 as a tumor suppressor gene with antiinvasive activity in nasopharyngeal carcinoma. Int J Cancer 2009; 17: 17.
38. Kerkela E, Saarialho-Kere U,. Matrix metalloproteinases in tumor progression: focus on basal and squamous cell skin cancer. Exp Dermatol 2003; 12: 109-25. (Pubitemid 36934696)
39. Bendrik C, Robertson J, Gauldie J, Dabrosin C,. Gene transfer of matrix metalloproteinase-9 induces tumor regression of breast cancer in vivo. Cancer Res 2008; 68: 3405-12.
40. Ferreras M, Felbor U, Lenhard T, Olsen BR, Delaisse J,. Generation and degradation of human endostatin proteins by various proteinases. FEBS Lett 2000; 486: 247-51.
41. Houghton AM, Grisolano JL, Baumann ML, Kobayashi DK, Hautamaki RD, Nehring LC, Cornelius LA, Shapiro SD,. Macrophage elastase (matrix metalloproteinase-12) suppresses growth of lung metastases. Cancer Res 2006; 66: 6149-55.
42. Patterson BC, Sang QA,. Angiostatin-converting enzyme activities of human matrilysin (MMP-7) and gelatinase B/type IV collagenase (MMP-9). J Biol Chem 1997; 272: 28823-5. (Pubitemid 27498157)
43. Lettau I, Hattermann K, Held-Feindt J, Brauer R, Sedlacek R, Mentlein R,. Matrix Metalloproteinase-19 is Highly Expressed in Astroglial Tumors and Promotes Invasion of Glioma Cells. J Neuropathol Exp Neurol, in press.
44. Muller M, Beck IM, Gadesmann J, Karschuk N, Paschen A, Proksch E, Djonov V, Reiss K, Sedlacek R,. MMP19 is upregulated during melanoma progression and increases invasion of melanoma cells. Mod Pathol, in press.
45. Lu J, Chua HH, Chen SY, Chen JY, Tsai CH,. Regulation of matrix metalloproteinase-1 by Epstein-Barr virus proteins. Cancer Res 2003; 63: 256-62. (Pubitemid 36070448)